medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 24, 2024
Abstract
Introduction
COVID-19
infection
caused
by
SARS-CoV-2
has
led
to
significant
long-term
health
challenges,
including
Long
COVID
or
Post-COVID
condition,
that
can
include
symptoms
such
as
cognitive
decline,
memory
loss,
and
concentration
issues.
This
study
investigates
the
prevalence
risk
factors
of
post-COVID
among
individuals
tested
for
COVID-19.
Methods
A
cross-sectional
was
conducted
in
Lisbon
Tagus
Valley,
targeting
August
2022.
Participants
were
selected
from
a
random
sample
10,000
individuals.
Data
collected
via
computer-assisted
telephone
interviews
at
9
12
months
post-test,
covering
sociodemographic
details,
behaviors,
pre-existing
conditions,
symptoms.
The
primary
outcome
presence
least
one
symptom
(memory
loss
and/or
issues)
months.
Additionally,
each
assessed
individually,
along
with
composite
both
concurrently.
Results
At
months,
reported
24.87%
positive
cases
versus
10.20%
negatives,
issues
15.45%
positives
7.45%
negatives.
16.67%
9.45%
while
9.82%
2.99%
28.24%
compared
12.16%
17.81%
9.95%
Female
sex
significantly
associated
higher
time
points.
Discussion
These
findings
underscore
enduring
impact
COVID-19,
disparities
between
negative
observed
post-infection.
suggests
potential
neurological
sequelae
linked
infection.
Notably,
association
female
increased
warrants
further
investigation
into
gender-specific
vulnerabilities
biological
mechanisms
underlying
these
disparities.
Addressing
persistent
is
crucial
patient
management
underscores
need
targeted
interventions
comprehensive
care
strategies
mitigate
long-lasting
implications.
European Archives of Psychiatry and Clinical Neuroscience,
Journal Year:
2024,
Volume and Issue:
274(8), P. 1945 - 1957
Published: July 24, 2024
Abstract
Some
people
infected
with
SARS-CoV-2
report
persisting
symptoms
following
acute
infection.
If
these
persist
for
over
three
months,
they
are
classified
as
post-COVID-19
syndrome
(PCS).
Although
PCS
is
frequently
reported,
detailed
longitudinal
neuropsychological
characterization
remains
scarce.
We
aimed
to
describe
the
trajectory
of
cognitive
and
neuropsychiatric
symptoms.
42
individuals
deficits
after
asymptomatic
mild/moderate
COVID-19
at
study
inclusion
received
assessment
baseline
(BL)
follow-up
(FU;
six
months
BL).
Assessments
included
comprehensive
testing
five
neurocognitive
domains,
two
screening
tests,
questionnaires
on
depression,
anxiety,
sleep,
fatigue,
health-related
quality
life.
Results
showed
high
rates
subjective
complaints
BL
FU
(95.2%
versus
88.1%)
without
significant
change
time.
However,
objectively
measured
disorder
(NCD)
decreased
(61.9%
42.9%).
All
domains
were
affected,
yet
most
found
in
learning
memory,
followed
by
executive
functions,
complex
attention,
language,
perceptual
motor
functions.
In
NCD,
first
mentioned
improved
significantly
time,
while
last
remained
unchanged.
Cognitive
tests
did
not
prove
valuable
detecting
impairment.
Neuropsychiatric
constant
except
life,
which
improved.
This
emphasizes
importance
research
provides
insights
into
long-term
impairments
PCS.
While
performance
many
Healthcare,
Journal Year:
2025,
Volume and Issue:
13(2), P. 196 - 196
Published: Jan. 19, 2025
Background/Objectives:
Among
the
neuropsychiatric
symptoms
of
long
COVID,
following
may
be
listed:
sleep
disturbances,
headaches,
anxiety,
depression,
dizziness,
numbness,
memory
loss,
and
concentration
difficulties.
Various
therapies
have
been
implemented
to
mitigate
these
symptoms;
however,
health
resort
treatments
that
utilize
a
wide
range
modalities
stimulating
multidirectional
biological
reactions
also
effective.
The
aim
this
study
was
assess
severity
in
COVID
patients
who
qualified
for
treatment,
evaluate
effectiveness
treatment
group
patients,
effect
balneological
factors
course.
Methods:
A
retrospective
analysis
medical
records
120
people
with
(69
women
51
men)
aged
42–79
underwent
2021
performed.
People
were
eligible
at
lowland
based
on
valid
referral
from
doctor.
included
therapies,
physical
medicine
modalities,
exercise
programs,
education,
psychological
support.
Patients
assessed
persistent
0–10
point
scale
before
after
treatment.
Results:
After
greatest
improvement
noted
disorders
(2.47
±
2.23
points
vs.
0.86
1.25
points,
p
<
0.00001)
dizziness
(1.39
1.94
0.34
0.76
0.00001).
lowest
observed
(2.68
2.5
1
1.4
Conclusions:
reported
mild
symptoms.
Health
mitigates
symptoms,
as
it
is
complex
approach.
Treatment
includes
improves
greater
extent.
This
method
should
integrated
into
standard
COVID.
PLoS ONE,
Journal Year:
2025,
Volume and Issue:
20(4), P. e0311449 - e0311449
Published: April 7, 2025
Severe
acute
respiratory
syndrome
corona
virus
2
(SARS-CoV-2)
can
cause
systemic
disease,
including
neurological
complications,
even
after
mild
disease.
Previous
studies
have
shown
that
SARS-CoV-2
infection
induce
neurovirulence
through
microglial
activation
in
the
brains
of
patients
and
experimentally
inoculated
animals,
which
are
models
representative
for
moderate
to
severe
Here,
we
aimed
investigate
neuroinvasive
neurovirulent
potential
intranasally
ferrets,
a
model
subclinical
The
presence
viral
RNA,
histological
lesions,
virus-infected
cells,
number
surface
area
microglia
astrocytes
were
investigated.
Viral
RNA
was
detected
various
tissue
samples
by
qPCR
at
7
days
post
inoculation
(dpi).
Virus
antigen
nasal
turbinates
ferrets
sacrificed
dpi
associated
with
inflammation.
dpi,
but
situ
hybridization
nor
immunohistochemistry
did
confirm
evidence
or
brain.
Histopathological
analysis
showed
no
an
influx
inflammatory
cells.
Despite
this,
observed
increased
Alzheimer
type
II
hindbrains
ferrets.
Additionally,
olfactory
bulb
hippocampus,
decrease
astrocytic
status
white
matter
hippocampus
In
conclusion,
although
has
limited
this
there
is
potential.
This
study
highlights
value
ferret
neuropathogenecity
reveals
affect
both
different
parts
Brain Sciences,
Journal Year:
2022,
Volume and Issue:
12(10), P. 1363 - 1363
Published: Oct. 8, 2022
A
better
understanding
of
biological
and
emotional
variables
associated
with
health-related
quality
life
in
people
long-COVID
is
needed.
Our
aim
was
to
identify
potential
direct
indirect
effects
on
the
relationships
between
sensitization-associated
symptoms,
mood
disorders
such
as
anxiety/depressive
levels,
sleep
suffering
from
post-COVID-19
pain.
One
hundred
forty-six
individuals
who
were
hospitalized
due
COVID-19
during
first
wave
pandemic
long-term
pain
completed
different
patient-reported
outcome
measures
(PROMs),
including
clinical
features,
symptoms
sensitization
central
nervous
system
(Central
Sensitization
Inventory),
(Hospital
Anxiety
Depressive
Scale),
(Pittsburgh
Sleep
Quality
Index),
(paper-based
five-level
version
EuroQol-5D)
a
face-to-face
interview
conducted
at
18.8
(SD
1.8)
months
after
hospitalization.
Different
mediation
models
assess
associations
among
variables.
The
revealed
that
depressive
levels
directly
affected
life;
however,
these
not
statistically
significant
when
included.
In
fact,
effect
symptomatology
(β
=
-0.10,
95%
CI
-0.1736,
-0.0373),
(β=
-0.09,
-0.1789,
-0.0314),
anxiety
-0.1648,
-0.0337)
all
indirectly
mediated
by
quality.
This
study
mediates
relationship
(depressive/anxiety
levels)
reporting
Longitudinal
studies
will
help
determine
implications
findings.
BMC Sports Science Medicine and Rehabilitation,
Journal Year:
2024,
Volume and Issue:
16(1)
Published: May 29, 2024
Abstract
Background
An
infection
with
SARS-CoV-2
can
lead
to
persistent
symptoms
more
than
three
months
after
the
acute
and
has
also
an
impact
on
patients’
physical
activity
behaviour
sleep
quality.
There
is
evidence,
that
inpatient
post-COVID
rehabilitation
improve
capacity
mental
health
impairments,
but
less
known
about
change
in
Methods
This
longitudinal
observational
study
used
accelerometery
assess
level
of
quality
before
program.
The
sample
consists
100
patients
who
acquired
COVID-19
workplace.
Group
differences
related
sex,
age,
severity,
pre-existing
diseases
were
analysed.
Results
Level
didn’t
increase
rehabilitation.
Overall,
there
a
high
extent
inactivity
time
poor
at
both
measurement
points.
Regarding
group
differences,
male
showed
significantly
higher
rehabilitation,
younger
(<
55
years)
spend
significant
vigorous
older
patients.
Post-COVID
cardiovascular,
respiratory,
metabolic
disease
show
slightly
without
these
comorbidities.
Female
better
some
parameters
However,
no
could
be
detected
severity.
Conclusions
Ongoing
strategies
should
implemented
address
amount
Clofazimine
and
Arbidol
have
both
been
reported
to
be
effective
in
vitro
SARS-CoV-2
fusion
inhibitors.
Both
are
promising
drugs
repurposed
for
treatment
of
COVID-19
used
several
previous
ongoing
clinical
trials.
Small-molecule
binding
expressed
constructs
the
trimeric
S2
segment
Spike
full-length
spike
protein
were
measured
using
a
Surface
Plasmon
Resonance
(SPR)
assay.
We
demonstrate
that
Clofazimine,
Toremifene,
other
derivatives
bind
protein.
provided
most
reliable
highest
quality
SPR
data
over
conditions
explored.
A
molecular
docking
approach
was
identify
favorable
sites
on
prefusion
conformation,
highlighting
two
possible
small-molecule
Results
from
modeling
structure-activity-relationship
(SAR)
newly
series
supports
proposed
site
segment.
When
is
superimposed
with
experimentally
determined
coronavirus
structures
structure-sequence
alignments,
changes
sequence
structure
may
rationalize
broad-spectrum
antiviral
activity
closely
related
such
as
(SARS-CoV,
MERS,
hCoV-229E,
hCoV-OC43).
Deleted Journal,
Journal Year:
2024,
Volume and Issue:
3(1), P. 358 - 358
Published: Jan. 23, 2024
The
impact
of
the
COVID-19
pandemic
on
people’s
lives
is
dramatic.
relationship
between
Brain
Fog
and
Long-COVID,
consequences
mental
health
patients,
its
treatment
are
objectives
this
systematic
review.
An
electronic
search
was
carried
out
databases
searched
included
PubMed,
Emerald,
EMBASE,
Science
Direct.
Regarding
review,
data
collection
English
papers
with
full
bibliographies,
abstracts,
keywords,
published
in
form
last
2
years
(2020–2022).
findings
indicate
importance
a
holistic
approach
Post-COVID
Fog.
It
also
necessary
for
healthcare
workers
to
investigate
biological
psychosocial
background
symptoms
detail
provide
appropriate
service.
However,
more
scientific
studies
needed
effectiveness
approaches
benefit
public
well-being.
Annals of Clinical and Translational Neurology,
Journal Year:
2024,
Volume and Issue:
11(8), P. 2188 - 2200
Published: July 4, 2024
To
reveal
the
clinical
features
and
assess
risk
factors
linked
to
brain
fog
its
societal
implications,
including
labor
productivity,
providing
valuable
insights
for
future
care
of
individuals
who
have
experienced
coronavirus
disease
2019
(COVID-19).
Biomedicines,
Journal Year:
2024,
Volume and Issue:
12(7), P. 1574 - 1574
Published: July 16, 2024
A
follow-up
study
was
designed
to
assess
correlations
among
physical
signs,
quality
of
sleep,
common
mental
symptoms,
and
health-related
life
after
moderate
severe
COVID-19
pneumonia.
Daily
changes
in
dyspnoea
pulse
oximetry
were
recorded
(200
days),
four
evaluations
(in
>2
years)
performed
on
cognitive
performance,
life.
In
a
single
center,
72
adults
participated
the
(52.5
±
13.7
years
old),
with
no
psychiatry/neurology/chronic
lung/infectious
diseases,
chronic
use
corticosteroids/immunosuppressive
therapy,
or
pregnancy.
agendas
showed
delayed
decreases
scores
compared
heart
rate
recordings;
however,
minimal.
Slight
performance
related
general
characteristics
participants
(obesity
tobacco
use)
severity
acute
disease
(MANCOVA,
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 23, 2024
Abstract
Severe
acute
respiratory
syndrome
corona
virus
2
(SARS-CoV-2)
can
cause
systemic
disease,
including
neurological
complications,
even
after
mild
disease.
Previous
studies
have
shown
that
SARS-CoV-2
infection
induce
neurovirulence
through
microglial
activation
in
the
brains
of
patients
and
experimentally
inoculated
animals,
which
are
models
representative
for
moderate
to
severe
Here,
we
aimed
investigate
neuroinvasive
neurovirulent
potential
intranasally
ferrets,
a
model
subclinical
The
presence
viral
RNA,
histological
lesions,
virus-infected
cells,
number
surface
area
microglia
astrocytes
were
investigated.
Viral
RNA
was
detected
various
tissue
samples
by
qPCR
at
7
days
post
inoculation
(dpi).
Virus
antigen
nasal
turbinates
ferrets
sacrificed
dpi
associated
with
inflammation.
dpi,
but
situ
hybridization
nor
immunohistochemistry
did
not
verify
evidence
infection.
Histopathological
analysis
showed
no
an
influx
inflammatory
cells.
Despite
this,
observed
increased
Alzheimer
type
II
hindbrains
ferrets.
Additionally,
olfactory
bulb
hippocampus,
decrease
astrocytic
status
white
matter
hippocampus
In
conclusion,
although
has
limited
this
there
is
potential.
This
study
highlights
value
ferret
neuropathogenecity
reveals
affect
both
different
parts
brain.